SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-319693
Filing Date
2011-11-22
Accepted
2011-11-22 14:12:36
Documents
4
Period of Report
2011-11-21
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d260193d8k.htm 8-K 26588
2 ARTICLES OF AMENDMENT TO AMENDED AND RESTATED ARTICLES OF INCORPORATION d260193dex31.htm EX-3.1 4976
3 PRESS RELEASE d260193dex991.htm EX-99.1 8443
4 GRAPHIC g260193g93g25.jpg GRAPHIC 6045
  Complete submission text file 0001193125-11-319693.txt   49852
Mailing Address 300 ELLIOTT AVENUE WEST SUITE 530 SEATTLE WA 98119-4114
Business Address 750 BATTERY STREET SUITE 330 SAN FRANCISCO CA 94111 2062862501
PONIARD PHARMACEUTICALS, INC. (Filer) CIK: 0000755806 (see all company filings)

IRS No.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16614 | Film No.: 111221533
SIC: 2834 Pharmaceutical Preparations